Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Test Type

  2.3.2 Market Size By Application

  2.3.3 Market Size By End-Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Test performance & diagnostic accuracy metrics

4.1.1 Share (%) of demand by test type (elisa, enzyme fluoroimmunoassay, rapid/lateral flow test, others).

4.1.2 Improvement (%) in sensitivity, specificity, and diagnostic accuracy.

4.1.3 Reduction (%) in false positives, false negatives, and diagnostic errors.

4.2 Application efficiency & clinical outcome metrics

4.2.1 Share (%) of usage by application (ibd diagnosis, colorectal cancer screening, disease monitoring, others).

4.2.2 Improvement (%) in early disease detection, monitoring effectiveness, and patient outcomes.

4.2.3 Reduction (%) in invasive procedures and diagnostic delays.

4.3 End-user adoption & workflow efficiency metrics

4.3.1 Share (%) of demand by end user (hospitals & clinics, diagnostic laboratories, others).

4.3.2 Improvement (%) in laboratory workflow efficiency and testing turnaround time.

4.3.3 Growth (%) in adoption driven by increasing prevalence of gastrointestinal disorders.

4.4 Cost efficiency & accessibility metrics

4.4.1 Reduction (%) in diagnostic costs compared to invasive procedures.

4.4.2 Improvement (%) in test accessibility and availability across healthcare settings.

4.4.3 Increase (%) in adoption of rapid testing solutions for point-of-care diagnostics.

5. Fecal Calprotectin Testing Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 ELISA

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

 5.3 Enzyme Fluoroimmunoassay [EIA]

 5.4 Rapid/Lateral Flow Test

 5.5 Others

6. Fecal Calprotectin Testing Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 IBD Diagnosis

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3 Colorectal Cancer Screening

 6.4 Disease Monitoring

 6.5 Others

7. Fecal Calprotectin Testing Market Segmental Analysis & Forecast, By End-Use, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals & Clinics

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 Diagnostic Laboratories

    7.4 Others

8. Fecal Calprotectin Testing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Fecal Calprotectin Testing Market Size & Forecast, By Test Type, 2022–2035

 8.2.3 Fecal Calprotectin Testing Market Size & Forecast, By Application, 2022–2035

 8.2.4 Fecal Calprotectin Testing Market Size & Forecast, By End-Use, 2022–2035

 8.2.5 Fecal Calprotectin Testing Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Fecal Calprotectin Testing Market Size & Forecast, By Test Type, 2022–2035

 8.3.3 Fecal Calprotectin Testing Market Size & Forecast, By Application, 2022–2035

 8.3.4 Fecal Calprotectin Testing Market Size & Forecast, By End-Use, 2022–2035

 8.3.5 Fecal Calprotectin Testing Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Fecal Calprotectin Testing Market Size & Forecast, By Test Type, 2022–2035

 8.4.3 Fecal Calprotectin Testing Market Size & Forecast, By Application, 2022–2035

 8.4.4 Fecal Calprotectin Testing Market Size & Forecast, By End-Use, 2022–2035

 8.4.5 Fecal Calprotectin Testing Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Fecal Calprotectin Testing Market Size & Forecast, By Test Type, 2022–2035

 8.5.3 Fecal Calprotectin Testing Market Size & Forecast, By Application, 2022–2035

 8.5.4 Fecal Calprotectin Testing Market Size & Forecast, By End-Use, 2022–2035

 8.5.5 Fecal Calprotectin Testing Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Fecal Calprotectin Testing Market Size & Forecast, By Test Type, 2022–2035

 8.6.3 Fecal Calprotectin Testing Market Size & Forecast, By Application, 2022–2035

 8.6.4 Fecal Calprotectin Testing Market Size & Forecast, By End-Use, 2022–2035

 8.6.5 Fecal Calprotectin Testing Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 BÜHLMANN Laboratories AG.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Roche Diagnostics AG

9.6.3 DiaSorin SpA

9.6.4 Thermo Fisher Scientific Inc.

9.6.5 Immundiagnostik AG

9.6.6 R-Biopharm AG

9.6.7 ScheBo Biotech AG

9.6.8 Calprotectin Testing Services Ltd.

9.6.9 Hycult Biotech BV

9.6.10 IBL International (Tecan)

9.6.11 Savyon Diagnostics Ltd.

9.6.12 Trinity Biotech plc

9.6.13 GenWay Biotech Inc.

9.6.14 Creative Diagnostics

9.6.15 Alpha Laboratories Ltd.

9.6.16 Epitope Diagnostics Inc.

9.6.17 NovaTec Immundiagnostica GmbH

9.6.18 Werfen Group (QUANTA Diagnostics)

9.6.19 Medipan GmbH

9.6.20 Biotecna Diagnostic SL

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures